Outcomes from the TITAN Study in mCSPC

Outcomes from the TITAN Study in mCSPC
Don Photo

Don
3 years 109 Views
Category:
Description:
William Oh, MD, Chief of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai discusses the outcomes of the TITAN study in metastatic castration-sensitive prostate cancer (mCSPC).